| Patient | Zelda Fitzgerald |
|---|---|
| Date of birth | 1900-07-24 |
| Identifiers | MRN HR-ET004-SYN-TD; SSN (made up) 000-04-8712 |
| Document date | 2026-11-01 |
| Author | Margot Ellery, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis and differential, antipsychotic monitoring baseline, missed periods, eating and exercise, and safety planning. Concerns: She wants to understand what happened and to make sure it never happens again; She wants to dance again and is afraid that medicines will make her gain weight; She is worried that her periods have stopped. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Risperidone 2 mg oral tablet, one tablet by mouth at bedtime (started in hospital) | One tablet by mouth at bedtime | Oral route | 1930-04-20 to 1930-06-08 | completed | S |
| Lithium carbonate 300 mg oral capsule, one capsule by mouth twice daily | One capsule by mouth twice daily | Oral route | 1930-05-18 | active | S |
| Risperidone 1 mg oral tablet, one tablet by mouth at bedtime for one week, then stop | One tablet by mouth at bedtime for one week | Oral route | 1930-06-08 to 1930-06-15 | completed | S |
| Aripiprazole 10 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 1930-06-08 | active | S |
| Folic acid 0.4 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1930-09-14 | active | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Insertion of a levonorgestrel intrauterine system after a negative pregnancy test | 1930-09-14 to 1930-09-14 | completed | S |
| Advance care planning conversation with a psychiatric advance directive, about 18 minutes | 1930-09-14 to 1930-09-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1930-09-14 | Influenza vaccine, 1930-1931 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| about 1927 | Intensive ballet training from her late twenties, morning and afternoon, almost eight hours a day | D (CLM-0003) |
| 1930 | First breakdown, with hospitalization for nervous exhaustion on a trip to Europe | D (CLM-0004) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| She wants to understand what happened and to make sure it never happens again | active | S |
| She wants to dance again and is afraid that medicines will make her gain weight | active | S |
| She is worried that her periods have stopped | active | S |
Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.1 on 1930-05-11; Hemoglobin [Mass/volume] in Blood 12.6 on 1930-05-11; Platelets [#/volume] in Blood by Automated count 248 on 1930-05-11; Sodium [Moles/volume] in Serum or Plasma 139 on 1930-10-26; Potassium [Moles/volume] in Serum or Plasma 4 on 1930-10-26; Creatinine [Mass/volume] in Serum or Plasma 0.79 on 1930-10-26; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M 103 on 1930-10-26; Glucose [Mass/volume] in Serum or Plasma 80 on 1930-06-01; Calcium [Mass/volume] in Serum or Plasma 9.6 on 1930-08-10; Thyrotropin [Units/volume] in Serum or Plasma 3.1 on 1930-10-26; Prolactin [Mass/volume] in Serum or Plasma 14 on 1930-08-10; Hemoglobin A1c/Hemoglobin.total in Blood 5.1 on 1930-08-10; Cholesterol [Mass/volume] in Serum or Plasma 174 on 1930-08-10; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 94 on 1930-08-10; Cholesterol in HDL [Mass/volume] in Serum or Plasma 62 on 1930-08-10; Triglyceride [Mass/volume] in Serum or Plasma 82 on 1930-08-10; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1930-09-14; Total score [AUDIT-C] 1 on 1930-09-14; Lithium [Moles/volume] in Serum or Plasma 0.72 on 1930-10-26; Fasting glucose [Mass/volume] in Serum or Plasma 86 on 1930-08-10 [S]
Strengths and supports: Supports: her friend and roommate, her dance class, and the coordinated specialty care team; writing and painting are her strongest sources of purpose. She decides who is told about her health [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| First episode of psychosis with marked mood symptoms: about three weeks of little sleep, rapid speech, racing thoughts, grandiose plans and very long training days, then a voice commenting on her dancing and a belief that she was being watched and tested; tearful low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, schizoaffective disorder (bipolar type), and schizophreniform disorder or schizophrenia, depending on whether the psychosis ever occurred apart from the mood symptoms. Synthetic modern episode linked to her documented first hospitalization | resolved | provisional | F29 | S — Synthetic modern coding of the documented first breakdown. Unspecified psychosis is coded until the course shows how the psychosis relates to the mood symptoms; superseded at the three-month visit. |
| Bipolar I disorder, most recent episode manic with psychotic features, in full remission: the working diagnosis at three months, when her history, her journal, and her roommate's account (given with her consent) showed that the voice and the belief she was watched began only after weeks of manic symptoms and ended with them, with no psychosis since. Remains provisional: it would be revised to schizoaffective disorder if psychosis ever lasted two weeks or more without a mood episode. Synthetic modern episode linked to the documented breakdown and its retrospective interpretations | active | provisional | F31.74 | S — Synthetic modern diagnosis made from the course; the historical diagnoses stay in the claims. |
| Secondary amenorrhea: no periods for about four months before admission, during very heavy dance training at a low weight (BMI 18.7), with prolactin raised on risperidone; pregnancy test negative | resolved | confirmed | N91.1 | S — Synthetic presenting finding linked to her documented training; resolved when her periods returned. |
| Acute viral gastroenteritis (vomiting and watery diarrhea for two days, roommate with the same illness), with mild dehydration; resolved | resolved | confirmed | A08.4 | S — Synthetic acute infection; not a historical claim. |
| Lithium level above the therapeutic range (1.4 mmol/L) during dehydration, with nausea and a worse fine tremor, without confusion or unsteadiness; lithium held and restarted; resolved | resolved | confirmed | T43.595A | S — Synthetic medication adverse effect at a prescribed dose; ICD-10-CM classifies lithium salts with the other antipsychotics and neuroleptics. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1930-05-11 | Leukocytes [#/volume] in Blood by Automated count | 6.1 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1930-05-11 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 11.6-15 g/dL | Normal | S |
| 1930-05-11 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1930-05-11 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1930-05-11 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1930-05-11 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1930-05-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M | 116 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1930-05-11 | Glucose [Mass/volume] in Serum or Plasma | 84 | mg/dL | 70-99 mg/dL | Normal | S |
| 1930-05-11 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.2 mg/dL | Normal | S |
| 1930-05-11 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1930-05-11 | Prolactin [Mass/volume] in Serum or Plasma | 62 | ng/mL | 4.8-23.3 ng/mL | High | S |
| 1930-05-11 | Hemoglobin A1c/Hemoglobin.total in Blood | 5 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | Normal | S |
| 1930-05-11 | Cholesterol [Mass/volume] in Serum or Plasma | 168 | mg/dL | <=199 mg/dL | Normal | S |
| 1930-05-11 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 90 | mg/dL | <=129 mg/dL | Normal | S |
| 1930-05-11 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 64 | mg/dL | >=50 mg/dL | Normal | S |
| 1930-05-11 | Triglyceride [Mass/volume] in Serum or Plasma | 70 | mg/dL | <=149 mg/dL | Normal | S |
| 1930-05-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 11 | {score} | S | ||
| 1930-05-11 | Total score [AUDIT-C] | 2 | {score} | S | ||
| 1930-05-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S | ||
| 1930-06-01 | Sodium [Moles/volume] in Serum or Plasma | 134 | mmol/L | 135-145 mmol/L | Low | S |
| 1930-06-01 | Potassium [Moles/volume] in Serum or Plasma | 3.4 | mmol/L | 3.5-5.1 mmol/L | Low | S |
| 1930-06-01 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 1930-06-01 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M | 71 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1930-06-01 | Glucose [Mass/volume] in Serum or Plasma | 80 | mg/dL | 70-99 mg/dL | Normal | S |
| 1930-06-01 | Lithium [Moles/volume] in Serum or Plasma | 1.4 | mmol/L | Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range | High | S |
| 1930-06-08 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1930-06-08 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1930-06-08 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1930-06-08 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M | 105 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1930-06-08 | Lithium [Moles/volume] in Serum or Plasma | 0.8 | mmol/L | Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range | Normal | S |
| 1930-06-08 | Prolactin [Mass/volume] in Serum or Plasma | 66 | ng/mL | 4.8-23.3 ng/mL | High | S |
| 1930-06-08 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 1930-08-10 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1930-08-10 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1930-08-10 | Creatinine [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1930-08-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M | 102 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1930-08-10 | Lithium [Moles/volume] in Serum or Plasma | 0.74 | mmol/L | Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range | Normal | S |
| 1930-08-10 | Thyrotropin [Units/volume] in Serum or Plasma | 2.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1930-08-10 | Calcium [Mass/volume] in Serum or Plasma | 9.6 | mg/dL | 8.6-10.2 mg/dL | Normal | S |
| 1930-08-10 | Prolactin [Mass/volume] in Serum or Plasma | 14 | ng/mL | 4.8-23.3 ng/mL | Normal | S |
| 1930-08-10 | Fasting glucose [Mass/volume] in Serum or Plasma | 86 | mg/dL | 70-99 mg/dL | Normal | S |
| 1930-08-10 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.1 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes | Normal | S |
| 1930-08-10 | Cholesterol [Mass/volume] in Serum or Plasma | 174 | mg/dL | <=199 mg/dL | Normal | S |
| 1930-08-10 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 94 | mg/dL | <=129 mg/dL | Normal | S |
| 1930-08-10 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 62 | mg/dL | >=50 mg/dL | Normal | S |
| 1930-08-10 | Triglyceride [Mass/volume] in Serum or Plasma | 82 | mg/dL | <=149 mg/dL | Normal | S |
| 1930-08-10 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1930-10-26 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1930-10-26 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1930-10-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.79 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1930-10-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1925)/1.73 sq M | 103 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1930-10-26 | Lithium [Moles/volume] in Serum or Plasma | 0.72 | mmol/L | Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range | Normal | S |
| 1930-10-26 | Thyrotropin [Units/volume] in Serum or Plasma | 3.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1930-10-26 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1930-09-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1930-09-14 | Total score [AUDIT-C] | 1 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1930-05-11 | Body height | 165 | cm | S |
| 1930-05-11 | Body weight | 50.8 | kg | S |
| 1930-05-11 | Body mass index (BMI) [Ratio] | 18.7 | kg/m2 | S |
| 1930-05-11 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1930-05-11 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1930-05-11 | Heart rate | 78 | /min | S |
| 1930-05-11 | Respiratory rate | 14 | /min | S |
| 1930-05-11 | Body temperature | 36.6 | Cel | S |
| 1930-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1930-05-18 | Body height | 165 | cm | S |
| 1930-05-18 | Body weight | 51 | kg | S |
| 1930-05-18 | Body mass index (BMI) [Ratio] | 18.7 | kg/m2 | S |
| 1930-05-18 | Systolic blood pressure | 106 | mm[Hg] | S |
| 1930-05-18 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1930-05-18 | Heart rate | 76 | /min | S |
| 1930-05-18 | Respiratory rate | 14 | /min | S |
| 1930-05-18 | Body temperature | 36.5 | Cel | S |
| 1930-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1930-06-08 | Body height | 165 | cm | S |
| 1930-06-08 | Body weight | 50.2 | kg | S |
| 1930-06-08 | Body mass index (BMI) [Ratio] | 18.4 | kg/m2 | S |
| 1930-06-08 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1930-06-08 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1930-06-08 | Heart rate | 74 | /min | S |
| 1930-06-08 | Respiratory rate | 14 | /min | S |
| 1930-06-08 | Body temperature | 36.6 | Cel | S |
| 1930-06-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1930-08-10 | Body height | 165 | cm | S |
| 1930-08-10 | Body weight | 51.6 | kg | S |
| 1930-08-10 | Body mass index (BMI) [Ratio] | 19 | kg/m2 | S |
| 1930-08-10 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1930-08-10 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1930-08-10 | Heart rate | 70 | /min | S |
| 1930-08-10 | Respiratory rate | 14 | /min | S |
| 1930-08-10 | Body temperature | 36.6 | Cel | S |
| 1930-08-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1930-10-26 | Body height | 165 | cm | S |
| 1930-10-26 | Body weight | 52.4 | kg | S |
| 1930-10-26 | Body mass index (BMI) [Ratio] | 19.2 | kg/m2 | S |
| 1930-10-26 | Systolic blood pressure | 110 | mm[Hg] | S |
| 1930-10-26 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 1930-10-26 | Heart rate | 68 | /min | S |
| 1930-10-26 | Respiratory rate | 14 | /min | S |
| 1930-10-26 | Body temperature | 36.5 | Cel | S |
| 1930-10-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1930-06-01 | Body height | 165 | cm | S |
| 1930-06-01 | Body weight | 49.6 | kg | S |
| 1930-06-01 | Body mass index (BMI) [Ratio] | 18.2 | kg/m2 | S |
| 1930-06-01 | Systolic blood pressure | 102 | mm[Hg] | S |
| 1930-06-01 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1930-06-01 | Heart rate | 104 | /min | S |
| 1930-06-01 | Respiratory rate | 16 | /min | S |
| 1930-06-01 | Body temperature | 37.7 | Cel | S |
| 1930-06-01 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| 1930-09-14 | Body height | 165 | cm | S |
| 1930-09-14 | Body weight | 51.9 | kg | S |
| 1930-09-14 | Body mass index (BMI) [Ratio] | 19.1 | kg/m2 | S |
| 1930-09-14 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1930-09-14 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1930-09-14 | Heart rate | 68 | /min | S |
| 1930-09-14 | Respiratory rate | 14 | /min | S |
| 1930-09-14 | Body temperature | 36.6 | Cel | S |
| 1930-09-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1930-05-11 | Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis and differential, antipsychotic monitoring baseline, missed periods, eating and exercise, and safety planning | finished | S |
| 1930-05-18 | One-week review and psychiatry consultation with the coordinated specialty care team | finished | S |
| 1930-06-08 | Lithium level after the sick visit, prolactin, and the antipsychotic plan | finished | S |
| 1930-08-10 | Three-month review: lithium, thyroid, kidney and metabolic checks, and the diagnosis reviewed | finished | S |
| 1930-10-26 | Six-month review: maintenance treatment, lithium monitoring, and movement check | finished | S |
| 1930-06-01 | Same-day sick visit for gastroenteritis on lithium | finished | S |
| 1930-09-14 | Periodic adult preventive visit with contraception | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Continue the antipsychotic started in hospital, with monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose or A1c and lipids at baseline, 12 weeks and yearly, prolactin because her periods have stopped, side-effect checks, and the AIMS at baseline and every six months | completed | GL-APA-SCZ-2020, GL-ADA-APA-2004, GL-CMID-2026 | S |
| Psychiatry consultation with the first-episode psychosis coordinated specialty care team on the provisional diagnosis and how to settle it, a mood stabilizer to prevent another episode, and the antipsychotic choice given her raised prolactin and missed periods | completed | GL-CANMAT-BD-2018, GL-APA-SCZ-2020, GL-NIMH-CSC | S |
| Reproductive health on psychiatric medicines: a pregnancy test before any new medicine, valproate avoided because of its risks in pregnancy, counseling on the risks of any mood stabilizer in pregnancy, contraception that suits her, folic acid, and planning with psychiatry before any pregnancy | completed | GL-CANMAT-BD-2018, GL-CDC-SPR-2024 | S |
| Eating and exercise: the SCOFF screen, menstrual and energy review at each visit, a sports dietitian, and a graded return to dance with food matched to the training load; training hours watched as an early warning sign | completed | GL-APA-SCZ-2020, GL-CANMAT-BD-2018 | S |
| Coordinated specialty care: a care coordinator, individual therapy with psychoeducation about mood and psychosis, education for the people she chooses, support to return to dance and writing, and a peer specialist | completed | GL-NIMH-CSC, GL-APA-SCZ-2020 | S |
| Sleep and early warning signs: regular sleep and wake times, no all-night writing or training, and a plan to call the team after two short nights or if training hours climb | completed | GL-CANMAT-BD-2018 | S |
| Lithium carbonate 300 mg twice daily after a negative pregnancy test, with 12-hour trough levels 5 to 7 days after starting and after any change, then every 3 to 6 months (target 0.6 to 0.8 mmol/L); creatinine and eGFR every 2 to 3 months for 6 months, then every 6 to 12; TSH once or twice in the first 6 months, then every 6 to 12; calcium yearly; and sick-day rules: hold it during vomiting, diarrhea or dehydration, and avoid anti-inflammatory painkillers | completed | GL-CANMAT-BD-2018, GL-CANMAT-BD-2023, GL-CMID-2026 | S |
| Switch from risperidone to aripiprazole: aripiprazole 10 mg daily with risperidone 1 mg for one week, then risperidone stopped; prolactin and periods checked at three months | completed | GL-APA-SCZ-2020, GL-CANMAT-BD-2018 | S |
| Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, the PHQ-9 at each visit, and safety review at every visit | completed | GL-SUICIDE-2024, GL-CMID-2026, GL-USPSTF-DEP-2023 | S |
| Lithium sick-day plan, written down and shared with her roommate with her consent: stop lithium during vomiting, diarrhea, fever with poor drinking, or heavy sweating without fluids, and call the clinic; restart when eating and drinking normally; no anti-inflammatory painkillers; and go to the emergency department for confusion, unsteadiness, slurred speech, or a coarse tremor | completed | GL-CANMAT-BD-2018, GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| No manic, depressive or psychotic episode and no readmission through six months | 1930-10-26 | completed | No episode and no admission; lithium and aripiprazole continued | S |
| Lithium trough level 0.6 to 0.8 mmol/L with normal kidney and thyroid tests at six months | 1930-10-26 | completed | Lithium 0.72 mmol/L; creatinine 0.79 mg/dL; TSH 3.1 mIU/L | S |
| Periods return and prolactin is normal by three months | 1930-08-10 | completed | Periods returned five weeks after the switch to aripiprazole; prolactin 14 ng/mL | S |
| BMI at least 19, with food matched to her training, by six months | 1930-10-26 | completed | BMI 19.2 at 52.4 kg, dancing about four hours a day | S |
| PHQ-9 score below 5 by six months | 1930-10-26 | completed | PHQ-9 3 | S |
Structured synthetic safety assessment on 1930-05-11: current ideation absent, intent absent, plan absent. Outpatient care with close follow-up. She has no thoughts of suicide or self-harm now and had none during the admission. Her risk is higher in the months after a first episode, and especially in a depressive phase after mania, so a written safety plan was made with her, with her own early warning signs (sleeping less, training for hours, racing thoughts, or feeling hopeless) and what to do about each. Lethal-means counseling: she has no firearm and no access to one; any medicine that is dangerous in overdose will be dispensed in small amounts while her mood is low. The 988 Suicide & Crisis Lifeline was given and saved in her phone, with the clinic number. Safety reviewed at every visit [S]